Role of proinflammatory markers and NT-proBNP in patients with an implantable cardioverter-defibrillator and an electrical storm

Cytokine

Volumn 47, Issue 3, 2009, Pages 166-172

  Streitner, Florian ^a   Kuschyk, Juergen ^a   Veltmann, Christian ^a   Ratay, Desiree ^a   Schoene, Nina ^a   Streitner, Ines ^a   Brueckmann, Martina ^a   Schumacher, Burghard ^b   Borggrefe, Martin ^a   Wolpert, Christian ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b Centre of Cardiovascular Medicine   (Germany)

Author keywords

Electrical storm; High sensitivity C reactive protein; Implantable cardioverter defibrillator; Interleukin 6; N terminal prohormone of B type natriuretic peptide

Indexed keywords

AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; C REACTIVE PROTEIN; INTERLEUKIN 6;

AGED; ARTICLE; CONGESTIVE CARDIOMYOPATHY; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DEFIBRILLATOR; DISEASE MARKER; FEMALE; HEART VENTRICLE FIBRILLATION; HEART VENTRICLE TACHYCARDIA; HIGH RISK PATIENT; HUMAN; INFLAMMATION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL;

AGED; BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; DEFIBRILLATORS, IMPLANTABLE; FEMALE; FOLLOW-UP STUDIES; HUMANS; INCIDENCE; INFLAMMATION MEDIATORS; INTERLEUKIN-6; MALE; NATRIURETIC PEPTIDE, BRAIN; PEPTIDE FRAGMENTS; TACHYCARDIA, VENTRICULAR; VENTRICULAR FIBRILLATION;

EID: 69049106354     PISSN: 10434666     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cyto.2009.06.003     Document Type: Article

References (41)

1. Moss A.J., Hall W.J., Cannom D.S., Daubert J.P., Higgins S.L., Klein H., et al. Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia. Multicenter automatic defibrillator implantation trial investigators. N Engl J Med 335 (1996) 1933-1940
2. Moss A.J., Zareba W., Hall W.J., Klein H., Wilber D.J., Cannom D.S., et al. Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N Engl J Med 346 (2002) 877-883
3. Connolly S.J., Hallstrom A.P., Cappato R., Schron E.B., Kuck K.H., Zipes D.P., et al. Meta-analysis of the implantable cardioverter defibrillator secondary prevention trials. AVID, CASH and CIDS studies. Antiarrhythmics vs implantable defibrillator study. Cardiac arrest study Hamburg. Canadian implantable defibrillator study. Eur Heart J 21 (2000) 2071-2078
4. DiMarco J.P. Implantable cardioverter-defibrillators. N Engl J Med 349 (2003) 1836-1847
5. Credner S.C., Klingenheben T., Mauss O., Sticherling C., and Hohnloser S.H. Electrical storm in patients with transvenous implantable cardioverter-defibrillators: incidence, management and prognostic implications. J Am Coll Cardiol 32 (1998) 1909-1915
6. Greene M., Newman D., Geist M., Paquette M., Heng D., and Dorian P. Is electrical storm in ICD patients the sign of a dying heart? Outcome of patients with clusters of ventricular tachyarrhythmias. Europace 2 (2000) 263-269
7. Exner D.V., Pinski S.L., Wyse D.G., Renfroe E.G., Follmann D., Gold M., et al. Electrical storm presages nonsudden death: the antiarrhythmics versus implantable defibrillators (AVID) trial. Circulation 103 (2001) 2066-2071
8. Israel C.W., and Serge Barold S. Electrical storm in patients with an implanted defibrillator: a matter of definition. Ann Noninvasive Electrocardiol 12 (2007) 375-382
9. Gatzoulis K.A., Andrikopoulos G.K., Apostolopoulos T., Sotiropoulos E., Zervopoulos G., Antoniou J., et al. Electrical storm is an independent predictor of adverse long-term outcome in the era of implantable defibrillator therapy. Europace 7 (2005) 184-192
10. Hohnloser S.H., Al-Khalidi H.R., Pratt C.M., Brum J.M., Tatla D.S., Tchou P., et al. Electrical storm in patients with an implantable defibrillator: incidence, features, and preventive therapy: insights from a randomized trial. Eur Heart J 27 (2006) 3027-3032
11. Deswal A., Misra A., and Bozkurt B. The role of anti-cytokine therapy in the failing heart. Heart Fail Rev 6 (2001) 143-151
12. Torre-Amione G., Kapadia S., Benedict C., Oral H., Young J.B., and Mann D.L. Proinflammatory cytokine levels in patients with depressed left ventricular ejection fraction: a report from the Studies of Left Ventricular Dysfunction (SOLVD). J Am Coll Cardiol 27 (1996) 1201-1206
13. Deten A., Volz H.C., Briest W., and Zimmer H.G. Cardiac cytokine expression is upregulated in the acute phase after myocardial infarction. Experimental studies in rats. Cardiovasc Res 55 (2002) 329-340
14. Ridker P.M., Rifai N., Stampfer M.J., and Hennekens C.H. Plasma concentration of interleukin-6 and the risk of future myocardial infarction among apparently healthy men. Circulation 101 (2000) 1767-1772
15. Aviles R.J., Martin D.O., Apperson-Hansen C., Houghtaling P.L., Rautaharju P., Kronmal R.A., et al. Inflammation as a risk factor for atrial fibrillation. Circulation 108 (2003) 3006-3010
16. Chung M.K., Martin D.O., Sprecher D., Wazni O., Kanderian A., Carnes C.A., et al. C-reactive protein elevation in patients with atrial arrhythmias: inflammatory mechanisms and persistence of atrial fibrillation. Circulation 104 (2001) 2886-2891
17. Gedikli O., Dogan A., Altuntas I., Altinbas A., Ozaydin M., Akturk O., et al. Inflammatory markers according to types of atrial fibrillation. Int J Cardiol 120 (2007) 193-197
18. Streitner F., Kuschyk J., Veltmann C., Brueckmann M., Streitner I., Brade J., et al. Prospective study of interleukin-6 and the risk of malignant ventricular tachyarrhythmia in ICD-recipients - A pilot study. Cytokine 40 (2007) 30-34
19. Blangy H., Sadoul N., Dousset B., Radauceanu A., Fay R., Aliot E., et al. hs-C-reactive protein, procollagen to assess the risk of ventricular tachycardia in ICD recipients after myocardial infarction. Europace 9 (2007) 724-729
20. Verma A., Kilicaslan F., Martin D.O., Minor S., Starling R., Marrouche N.F., et al. Preimplantation B-type natriuretic peptide concentration is an independent predictor of future appropriate implantable defibrillator therapies. Heart 92 (2006) 190-195
21. Yu H., Oswald H., Gardiwal A., Lissel C., and Klein G. Comparison of N-terminal pro-brain natriuretic peptide versus electrophysiologic study for predicting future outcomes in patients with an implantable cardioverter defibrillator after myocardial infarction. Am J Cardiol 100 (2007) 635-639
22. Devecchi P., Plebani L., Occhetta E., Bortnik M., Francalacci G., Magnani A., et al. Electrical storms in patients with implantable cardioverter-defibrillator: incidence and clinical management. G Ital Cardiol (Rome) 7 (2006) 695-701
23. Brigadeau F., Kouakam C., Klug D., Marquie C., Duhamel A., Mizon-Gerard F., et al. Clinical predictors and prognostic significance of electrical storm in patients with implantable cardioverter defibrillators. Eur Heart J 27 (2006) 700-707
24. Verma A., Kilicaslan F., Marrouche N.F., Minor S., Khan M., Wazni O., et al. Prevalence, predictors, and mortality significance of the causative arrhythmia in patients with electrical storm. J Cardiovasc Electrophysiol 15 (2004) 1265-1270
25. Christ M., Sharkova J., Bayrakcioglu S., Herzum I., Mueller C., and Grimm W. B-type natriuretic peptide levels predict event-free survival in patients with implantable cardioverter defibrillators. Eur J Heart Fail 9 (2007) 272-279
26. Klingenberg R., Zugck C., Becker R., Schellberg D., Heinze G., Kell R., et al. Raised B-type natriuretic peptide predicts implantable cardioverter-defibrillator therapy in patients with ischaemic cardiomyopathy. Heart 92 (2006) 1323-1324
27. Haverkate F., Thompson S.G., Pyke S.D., Gallimore J.R., and Pepys M.B. Production of C-reactive protein and risk of coronary events in stable and unstable angina. Lancet 349 (1997) 462-466
28. Fisman E.Z., Benderly M., Esper R.J., Behar S., Boyko V., Adler Y., et al. Interleukin-6 and the risk of future cardiovascular events in patients with angina pectoris and/or healed myocardial infarction. Am J Cardiol 98 (2006) 14-18
29. Shehab A.M., MacFadyen R.J., McLaren M., Tavendale R., Belch J.J., and Struthers A.D. Sudden unexpected death in heart failure may be preceded by short term, intraindividual increases in inflammation and in autonomic dysfunction: a pilot study. Heart 90 (2004) 1263-1268
30. Sajadieh A., Nielsen O.W., Rasmussen V., Ole Hein H., and Hansen J.F. Increased ventricular ectopic activity in relation to C-reactive protein, and NT-pro-brain natriuretic peptide in subjects with no apparent heart disease. Pacing Clin Electrophysiol 29 (2006) 1188-1194
31. Harris T.B., Ferrucci L., Tracy R.P., Corti M.C., Wacholder S., Ettinger Jr. W.H., et al. Associations of elevated interleukin-6 and C-reactive protein levels with mortality in the elderly. Am J Med 106 (1999) 506-512
32. Biasucci L.M., Giubilato G., Biondi-Zoccai G., Sanna T., Liuzzo G., Piro M., et al. C reactive protein is associated with malignant ventricular arrhythmias in patients with ischaemia with implantable cardioverter-defibrillator. Heart 92 (2006) 1147-1148
33. Giannessi D., Colotti C., Maltinti M., Del Ry S., Prontera C., Turchi S., et al. Circulating heat shock proteins and inflammatory markers in patients with idiopathic left ventricular dysfunction: their relationships with myocardial and microvascular impairment. Cell Stress Chaperones 12 (2007) 265-274
34. Spooner P.M., and Zipes D.P. Sudden death predictors: an inflammatory association. Circulation 105 (2002) 2595-2599
35. Sata N., Hamada N., Horinouchi T., Amitani S., Yamashita T., Moriyama Y., et al. C-reactive protein and atrial fibrillation. Is inflammation a consequence or a cause of atrial fibrillation?. Jpn Heart J 45 (2004) 441-445
36. Ellinor P.T., Low A., Patton K.K., Shea M.A., and MacRae C.A. C-Reactive protein in lone atrial fibrillation. Am J Cardiol 97 (2006) 1346-1350
37. Puljevic M., Nevajda B., Sicaja M., Pulevic D., and Milicic D. Influence of electrical cardioversion on troponine I and brain natriuretic peptide (NT-proBNP) levels in patients with persistent atrial fibrillation/flutter C-Reactive protein in lone atrial fibrillation. Lijec Vjesn 130 7-8 (2008) 175-178
38. Skulec R., Belohlavek J., Kovarnik T., Kolar J., Gandalavicova J., Dytrych V., et al. Serum cardiac markers response to biphasic and monophasic electrical cardioversion for supraventricular tachyarrhythmia - a randomised study. Resuscitation 70 3 (2006) 423-431 [Epub 2006 Aug 9]
39. Dernellis J., and Panaretou M. Relationship between C-reactive protein concentrations during glucocorticoid therapy and recurrent atrial fibrillation. Eur Heart J 25 (2004) 1100-1107
40. Conway D.S., and Lip G.Y. Inflammation, arrhythmia burden and the thrombotic consequences of atrial fibrillation. Eur Heart J 25 (2004) 1761
41. Shiroshita-Takeshita A., Brundel B.J., Lavoie J., and Nattel S. Prednisone prevents atrial fibrillation promotion by atrial tachycardia remodeling in dogs. Cardiovasc Res 69 (2006) 865-875